|
|
Legal status
Patent in force
| (51) | INT.CL. | C07D 271/08 | (2006.01) |
| C07D 413/04 | (2006.01) | ||
| A61K 31/4245 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 3066085 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14812015.7 |
| Date of filing the European patent application | 2014-11-07 | |
| (97) | Date of publication of the European application | 2016-09-14 |
| (45) | Date of publication and mention of the grant of the patent | 2020-05-13 |
| (46) | Date of publication of the claims translation | 2020-06-25 |
| (86) | Number | PCT/US2014/064531 |
| Date | 2014-11-07 |
| (87) | Number | WO 2015/070007 |
| Date | 2015-05-14 |
| (30) | Number | Date | Country code |
| 201361901689 P | 2013-11-08 | US |
| (72) |
TAO, Ming, US
FRIETZE, William, US
MELONI, David J., US
WENG, Lingkai, US
ZHOU, Jiacheng, US
PAN, Yongchun, US
|
| (73) |
Incyte Holdings Corporation,
1801 Augustine Cut-Off, Wilmington, DE 19803,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Indolamino 2,3-dioksigenazės inhibitoriaus sintezės būdas |
| PROCESS FOR THE SYNTHESIS OF AN INDOLEAMINE 2,3-DIOXYGENASE INHIBITOR |
| Payment date | Validity (years) | Amount | |
| 2024-11-06 | 11 | 289.00 EUR |
| 2025-11-07 |